View conference programme - The British Society for Rheumatology

OP63 ALTERED LIPID RAFT EXPRESSION AND ASSOCIATED SIGNALLING IN T LYMPHOCYTES
FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE).
EC Jury 1 , PS Kabouridis 2 , F Flores-Borja 2 , RA Mageed 2 , DA Isenberg 1 . 1
Centre for Rheumatology,
Royal Free and University College Medical School, University College London, London, United
Kingdom; 2 Bone and Joint Research Unit, Bats and The London, Queen Mary’s School of Medicine
and Dentistry, London, United Kingdom
OP64 SEROLOGICAL INVESTIGATION OF AUTOANTIBODIES IN 577 FAMILIES WITH SYSTEMIC
LUPUS ERYTHEMATOSUS.
S Chadha, CA Roberton, P Charles, J Whittaker, TJ Vyse. 1 Rheumatology Section, Eric Bywaters
Centre, Imperial College Faculty of Medicine, Hammersmith, London, United Kingdom; 2 Kennedy
Institute of Rheumatology, Imperial College Faculty of Medicine, London, United Kingdom;
3
Epidemiology and Public Health, Imperial College Faculty of Medicine, St Mary’s, London, United
Kingdom
OP65 GENETIC DISSECTION OF BXSB LUPUS PHENOTYPE USING MICE CONGENIC
FOR CHROMOSOME 1 DEMONSTRATES THAT SEPARATE INTERVALS DIRECT DIFFERENT
ASPECTS OF DISEASE.
MEK Haywood 1 , J Rose 1 , J Boyle 2 , AM McDermott 1 , JM Rankin 1 , S Izui 3 , MJ Walport 1 , BJ Morley 1 .
1
Rheumatology Section, Eric Bywaters Centre, Imperial College, London, United Kingdom;
2
Histopathology Department, Hammersmith Hospital, London, United Kingdom; 3 Department of
Pathology, Centre Medical Universitaire, Geneva, Switzerland
OP66 RECONSTITUTION OF C1q-DEFICIENCY WITH BONE MARROW DERIVED CELLS
AMELIORATES THE AUTOIMMUNITY ASSOCIATED WITH C1q-DEFICIENCY.
J Cortes-Hernandez 1 , L Fossati-Jimack 1 , S Izui 2 , F Petry 3 , M Loos 3 , MJ Walport 1 , M Botto 1 .
1
Rheumatology Section, Eric Bywaters Centre, Imperial College, London, London, United Kingdom;
2
Department of Pathology, University of Geneva, Geneva, Geneva, Switzerland; 3 Institute of
Medical Microbiology and Hygiene, Johannes Gutenberg-University, Mainz, Mainz, Germany
OP67 SEROLOGICAL CHANGES FOLLOWING B LYMPHOCYTE DEPLETION THERAPY
IN SYSTEMIC LUPUS ERYTHEMATOSUS.
MJ Leandro 1 , G Cambridge 1 , JCW Edwards 1 , M Teodorescu 2 , MR Ehrenstein 1 , DA Isenberg 1 .
1
Centre for Rheumatology, University College London, London, United Kingdom; 2 TheraTest Labs,
Lombard, IL, United States
OP68 QUALITY OF LIFE, FUNCTIONAL STATUS AND CLINICAL FEATURES AT PRESENTATION
IN POLYMYALGIA RHEUMATICA(PMR): RESULTS FROM A MULTI-CENTRE PROSPECTIVE
COHORT STUDY.
B Dasgupta 1 , A Hutchings 1,2 , J Hollywood 1 , D Lamping 2 , C Pease 3 , K Chakravarty 4 , B Hazleman 5 ,
B Silverman 5 , E Choy 6 , DGI Scott 7 , B Bourke 8 , N Gendi 9 . 1
Southend Hospital, Westcliff-on-sea,
United Kingdom; 2 London School of Hygiene & Tropical Medicine, London, United Kingdom;
3
Leeds General Infirmary, Leeds, United Kingdom; 4 Harold Wood Hospital, Romford, Essex, United
Kingdom; 5 Addenbrookes Hospital, Cambridge, United Kingdom; 6 King’s College London, London,
United Kingdom; 7 Norfolk & Norwich Hospital, Norwich, United Kingdom; 8 St George’s Hospital,
London, United Kingdom; 9 Basildon Hospital, Basildon, Essex, United Kingdom.
33